Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

TELO

+ Watchlist+ Portfolio

Telomir Pharmaceuticals, Inc.

Regulated industrySells to businessesDevelopment stageTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$0.42
52-Week Range
$0.40 – $1.58
Market Cap
$30.98M
P/E (TTM)
—
EPS (TTM)
-0.96
Dividend Yield
0.00%
Advanced Metrics
Price/Book
6.57
PEG Ratio
—
Return on Equity
-96.26%
Return on Assets
-59.01%
Gross Margin
0.00%
Operating Margin
0.00%
Profit Margin
0.00%
Current Ratio
19.61
Debt/Equity
0.02
Total Debt
$68.76K
Free Cash Flow
$-2.88M
Revenue Growth
—
Earnings Growth
—
Enterprise Value
$26.53M

Market Snapshot

About

Telomir Pharmaceuticals, Inc. is a biotechnology company focused on developing therapeutics to extend healthspan by addressing cellular aging and age-related diseases. The company is researching compounds that may influence telomere biology and cellular senescence. Telomir aims to develop treatments for conditions associated with aging and metabolic dysfunction.